Abstract:BACKGROUND: The molecular mechanism of blood vessel endothelium formation is the primary premise for cellular and gene replacement therapy. OBJECTIVE: To construct an eukaryotic expression plasmid for cellular repressor of E1A-stimulated genes (CREG) driven by an endothelial cell specific promoter TIE2 and reported by enhanced green fluorescence protein (EGFP), and then to observe its expression in mouse artery endothelial cells in vitro. METHODS: TIE2 promoter DNA sequence was synthesized according to GenBank, and was attached with Ase I and Nhe I restriction enzyme recognition sites at both ends, respectively. The TIE2 promoter sequence was released from pUC57-TIE2 plasmid by Ase I and Nhe I digestion enzymes, and then was inserted into pEGFP-N1 plasmid to form pTIE2-EGFP-N1 recombinant plasmid. CREG gene fragment was released from pcDNA3.1 myc-His/hCREG plasmid by BamH I and EcoR I digestion enzymes, and then was subcloned into pTIE2-EGFP-N1 plasmid in order to construct pTIE2-CREG-EGFP-N1 plasmid. The recombinant pTIE2-CREG-EGFP-N1 plasmid was then transfected into mouse artery endothelial cells by liposome. The EGFP expression was observed by fluorescence microscopy and the CREG expression was detected by western blot analysis. RESULTS AND CONCLUSION: Identification of pTIE2-CREG-EGFP-N1 by enzyme digestion and sequencing analysis showed that lengths of the target genes which were inserted into the recombinant plasmid were correct, and that the recombinant plasmid was transfected into mouse artery endothelial cells successfully. The strong expression of EGFP was observed by fluorescence microscopy, and the expression of CREG protein was detected by western blot analyis. The results showed that the pTIE2-CREG-EGFP-N1 eukaryotic expression plasmid was successfully constructed and the recombinant vector provides a practical tool in investigating the function and regulation of CREG in the development of cardiovascular diseases and also in producing transgenic mice with endothelial cell specific over-expression of CREG.

YFP-Cox7a2, Expressed, Located and Related to ERK1/2 Phosphorylation in Mouse TM3 Leydig Cells

Construction And Expression Of Cox7a2 Fluorescent Protein In Mouse Leydig Cells

Effect of Cox7a2 on steroidogenesis in TM3 mouse Leydig cell

P70S6K is Involved in the Inhibition of Testosterone Production in TM3 Mouse Leydig Cells Overexpressing Cox7a2

[Effect of Ras Signal Regulating Cox7a2 Expression and Its Sub-Cellular Location in Testicular Interstitial Cell].

[Construction and Expression of ATP50 Fluorescent Protein in TM3 Mouse Leydig Cells].

Construction of Pgex4t-1-cox7a2 and Expression, Purification and Identification of the Recombinant Protein

Expression of Cox7a2 and ATP50 in primary mouse Leydig cells and human different organs

Ras-ERK1/2 was involved in the regulation of late onset hypogonadism

ERO1α promotes testosterone secretion in hCG-stimulated mouse Leydig cells via activation of the PI3K/AKT/mTOR signaling pathway

Regulation of testosterone production of Leydig cells by activity of ROS induced by Cox7a2

Ferm Domain Containing Protein 7 (frmd7) Upregulates the Expression of Neuronal Cytoskeletal Proteins and Promotes Neurite Outgrowth in Neuro-2a Cells

Construction of pEGFP-C1-CXCL1 plasmid and detection of its expression in eukaryotic cells

Cell Type-Restricted Expression of Erythrocyte Tropomodulin Isoform41 in Exon 1 Knockout/lacz Knock-in Heterozygous Mice.

Expression And Identification Of Atp50 And Coxviia In Rat Leydig Cell

Genome-Wide Mapping Of In Vivo Er Alpha-Binding Sites In Male Mouse Efferent Ductules

The Expression of Estrogen Receptors in Rat Genioglossus Muscle-Derived Satellite Cells and Its Relationship to Intracellular Ca2+ Mobilization

TC1 (C8orf4) is involved in ERK1/2 pathway-regulated G1- to S-phase transition

Visualizing ER-phagy and ER Architecture in Vivo.

Supplementary Information from &Lt;i>tmprss2-Erg</i> Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in <i>pten</i> and &Lt;i>tp53</i>-Mutated Prostate Cancer

Construction of PTIE2-CREG-EGFP-N1 eukaryotic expression plasmid and its expression in mouse artery endothelial cells